Understanding of Genetics by Men at Risk for Prostate Cancer
Recruiting now · Not applicable
Conditions studied: Prostate Cancer
In brief
With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.
Key facts
- Study ID
- NCT04550845
- Run by
- Mayo Clinic
- People needed
- 90
- Starts
- 2023-05-01
- Expected to finish
- 2027-09-27
- Last updated by the study team
- 2025-11-06
Who can join
Age: 40 and older, up to 95. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- African-American or White men
- Living in a rural or urban areas
- Age 40 to 95 years old
- Able and willing to provide informed consent
- English-speaking
- Willing to participate in the study.
- This study will use the United States Department of Agriculture Office of Rural Development's definition of rural, which is as a city or town that has a population less than 50,000 inhabitants to define rural.
- This study will use the United States Census Bureau's definition of urban, which is a city or town that has a population greater than 50,000 inhabitants to define urban.
You may not qualify if…
- Women will be excluded from participating in this study. However, women will be recruited to serve on an advisory panel to review the video-based educational tool for the comprehension of genomic terminology for prognostic genetic testing in patients with localized prostate cancer.
Where it is running
- Mayo Clinic — Phoenix, Arizona, United States (enrolling)
- Mayo Clinic in Florida — Jacksonville, Florida, United States (enrolling)
- Mayo Clinic — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.